Filing Details

Accession Number:
0001209191-23-024109
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-12 16:58:33
Reporting Period:
2023-04-10
Accepted Time:
2023-04-12 16:58:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851194 Ventyx Biosciences Inc. VTYX Pharmaceutical Preparations (2834) 832996852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1878125 Raju Mohan C/O Ventyx Biosciences, Inc.
662 Encinitas Blvd., Ste. 250
Encinitas CA 92024
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-04-10 9,255 $29.01 1,573,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
  2. Represents the weighted average share price of an aggregate total of 9,255 shares sold in the price range of $29.00 to $29.11. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.